[New post] Viatris’ (VTRS) Q4 Earnings Miss, Biocon Biologics Deal Inked

Editorial Team posted: "Viatris (VTRS) misses on Q4 earnings but surpasses sales estimates. The company announces a combination of its biosimilars portfolio with Biocon Biologics. Find out more at https://ift.tt/zVmcyqO via Entrepreneur.com" New post on Technology & Business News Viatris' (VTRS) Q4 Earnings Miss, Biocon Biologics Deal Inked by Editorial Team Viatris (VTRS) misses on Q4 earnings but surpasses sales estimates. The company announces a combination of its biosimilars portfolio with Biocon Biologics. Find out more at https://ift.tt/zVmcyqO via Entrepreneur.com Read more of this post This free site is ad-supported. Learn more ​ Editorial Team | February 28, 2022 at 12:10 pm | Tags: Entrepreneur | Categories: Business | URL: https://wp.me/pcbvJV-gQx Like Unsubscribe to no longer receive posts from Technology & Business News. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://technologyandbusinessnews.wordpress.com/2022/02/28/viatris-vtrs-q4-earnings-miss-biocon-biologics-deal-inked/ Thanks for flying with WordPress.com